Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Caris Life Sciences, Inc. (CAI)

NASDAQ

$25,10

$-0,23

(-0,91%)

Previous Close: ⁦$25,32⁩

Market Closed

Caris Life Sciences, Inc. (CAI) Live Price Chart

Last updated: ⁦2026-09-05 19:52:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Caris Life Sciences, Inc. (CAI) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $25,10, with a market capitalisation of $7,16B and a P/E ratio of 67,39. Over the past 52 weeks, its price has ranged from $14,19 to $36,65. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$7,16B
Open	$24,88
Day's High	$69,18
Day's Low	$4,83
Previous Close	$25,32
Volume	4,29M
Average Volume	4,29M
P/E Ratio	67,39
52-Week High	$36,65
52-Week Low	$14,19
Dividend Yield	--
Earnings Date	--

Caris Life Sciences, Inc. (CAI) Latest Closing Stock Price

Caris Life Sciences, Inc. (CAI) last closed at $25,32 as of 2026-09-04 23:31:00, unchanged from the previous close of $25,32.

During the latest regular trading session, CAI traded between $4,83 and $69,18, with a volume of 4,29M shares. The closing price was near the lower end and near the middle of its 52-week range.

Caris Life Sciences, Inc. (CAI) 7-Day Stock Price Change

Over the past seven days, Caris Life Sciences, Inc. (CAI) moved from $26,38 to $25,10, representing a decline of 4,86% ($1,28).

The stock traded between $23,62 and $27,39 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 5,90 million shares, up versus the previous seven-day period, indicating higher trading activity.

CAI 52-Week Price Position

Position in Range: 48,6%

52W Low$14,19

52W High$36,65

CAI is currently trading at $25,10, placing it 48,6% of the way from its 52-week low of $14,19 to its 52-week high of $36,65. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Caris Life Sciences, Inc. (CAI)?

Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.

Caris Life Sciences, Inc. Information

Industry	SERVICES-MEDICAL LABORATORIES
Employees	1846
Exchange	NASDAQ
Company Website	https://www.carislifesciences.com

How to Buy Caris Life Sciences, Inc. (CAI) Stock on MEXC

Eligible investors can buy real shares of Caris Life Sciences, Inc. (CAI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CAI and Place Your Order

Open the RealStocks trading page and search for CAI. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Caris Life Sciences, Inc. (CAI) share price today?

Caris Life Sciences, Inc. (CAI) is currently trading at $ 25,10, down 0,87% ($0,22) from the previous close of $ 25,32. Intraday prices update in real time during regular trading hours.

2.Is CAI stock going up or down today?

As of 2026-09-04 23:31:00, CAI is trading at $ 25,10, down 0,87% ($0,22) from its previous close of $ 25,32. The stock has traded between $ 4,83 and $ 69,18 during today’s regular session. Past price movements do not guarantee future results.

3.What is CAI pre-market price?

As of 2026-09-04 23:31:00, CAI is trading at $ 25,15 in pre-market trading, down 0,67% ($0,17) from the previous close of $ 25,32. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CAI after-hours price?

As of 2026-09-04 23:31:00, CAI is trading at $ 25,09 in after-hours trading, down 0,93% ($0,23) from the regular-session close of $ 25,32. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is CAI stock trading now?

CAI trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CAI sit relative to its 52-week high and low?

Over the past 52 weeks, CAI has traded between a low of $ 14,19 and a high of $ 36,65. At $ 25,10, the stock is positioned 48,6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Caris Life Sciences, Inc. in?

Caris Life Sciences, Inc. (CAI) operates in the SERVICES-MEDICAL LABORATORIES sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Caris Life Sciences, Inc.'s market capitalisation and where is it listed?

Caris Life Sciences, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 7,16B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CAI valued in terms of P/E ratio and EPS?

CAI trades at a P/E ratio of 67,39, based on trailing-twelve-month EPS of $ 0,37. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Caris Life Sciences, Inc. pay a dividend?

Caris Life Sciences, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.